Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

HYTN Innovations Inc C.HYTN

HYTN Innovations Inc. is a Canada-based company that creates products containing psychoactive and psychotropic compounds, including cannabinoids derived from cannabis. The Company formulates, manufactures, markets, and sells cannabis goods. It is engaged in the development of the sparkling tetrahydrocannabinol and the cannabidiol beverage business. All its sparkling cannabis beverages contain 10 milligrams (mg) of THC and are made using its process, Elevation Technology. Its products include Rosewater Lemonade, Watermelon Mint, Lemongrass Ginger, and Blood Orange. Its Rosewater Lemonade is a sugar-free exploration of citrus accented with floral notes. Blood Orange is formulated to bring out the sweet flavors found in this seasonal citrus fruit. Its activities are focused on a single production and manufacturing facility, based in Kelowna, British Columbia. The Company’s subsidiaries include HYTN Innovations Inc., HYTN Beverage Corp, HYTN Cannabis Inc., and 1306562 B.C. Ltd.


CSE:HYTN - Post by User

Comment by RobSupraon Mar 01, 2022 4:01pm
94 Views
Post# 34472524

RE:RE:RE:RE:RE:RE:Yep aman parmar is in this one

RE:RE:RE:RE:RE:RE:Yep aman parmar is in this oneOk, so you convinced me that Chemesis and Aman Parmar could very well be bad actors, even though I do not know them at all.  However, from the public information I have seen does not suggest that they are anything more than shareholders.  They do not have a role on the board or management team.  Perhaps dig up some crediable information on what percentage of HYTN these characters hold...

In terms of Jason Broome, I think he did a reasonable job when he was at Flowr and my impression is that he is very good with operations and Health Canada interactions.  His participation is what has given me some confidence in what HYTN is engaged in, not people I know nothing about.
<< Previous
Bullboard Posts
Next >>